Bio Pharma Dive
MARCH 15, 2024
The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.
Pharmaceutical Technology
MARCH 15, 2024
Amidst the many BTK inhibitors, Breyanzi will be the first and only CAR-T cell therapy available for the treatment of CLL and SLL.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 15, 2024
A majority of experts believed that the factors that may have led to an increased risk of early death in testing of Carvykti and Abecma aren’t as likely to occur outside of a clinical trial.
Pharmaceutical Technology
MARCH 15, 2024
Madrigal’s Rezdiffra received an accelerated approval as a treatment for noncirrhotic NASH, also known as MASH.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MARCH 15, 2024
Sold as Breyanzi, the therapy is now cleared for use in certain adults with hard-to-treat forms of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Pharmaceutical Technology
MARCH 15, 2024
Anocca has entered a licensing agreement with EmendoBio for the use of the latter’s OMNI-A4 nuclease, a gene editing technology.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
MARCH 15, 2024
More than 3,700 cases of mpox have been identified in the UK since May 2022
Pharmaceutical Technology
MARCH 15, 2024
Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.
Fierce Pharma
MARCH 15, 2024
Even though the BCMA CAR-T therapy Carvykti showed a potential problem of early patient deaths in a trial, experts on the FDA’s Oncologic Drugs Advisory Committee (ODAC) still believe that the drug | Even though the BCMA CAR-T therapy Carvykti showed a potential problem of early patient deaths in a trial, experts on the FDA’s Oncologic Drugs Advisory Committee still believe that the drug’s long-term benefits outweigh its risks.
Pharmaceutical Technology
MARCH 15, 2024
The committee ultimately backed the benefits of imetelstat based on data from the Phase III IMerge clinical trial.
Fierce Pharma
MARCH 15, 2024
Over the years, Singapore has attracted a suite of biopharma majors, and Novartis is no exception. | Novartis broke ground on a $256 million expansion of its biopharmaceutical production facility in Singapore. The project will introduce digitalization and automation at the site in a bid to boost manufacturing productivity and to help upskill the company’s workforce.
Pharmaceutical Technology
MARCH 15, 2024
Biotheus has announced an expansion of its strategic partnership with Hansoh Pharmaceutical Group for antibody-drug conjugates (ADCs).
pharmaphorum
MARCH 15, 2024
Popular mobile messaging apps that offer end-to-end encryption for their users' communications means that the content of messages is only accessible to the sender and the recipient. However, like any software, they still have potential cybersecurity risks and compliance concerns that users should be aware of - especially in pharma.
Pharmaceutical Technology
MARCH 15, 2024
The US FDA has approved BeiGene's TEVIMBRA for oesophageal squamous cell carcinoma (ESCC) after previous systemic chemotherapy.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
MARCH 15, 2024
Explore the latest digital and supplier hires in the pharmaceutical industry, including Campbell, EMS Healthcare, PhRMA, and Exscientia in February 2024. Stay updated on the changing faces in industry.
Pharmaceutical Technology
MARCH 15, 2024
Noramco has announced the launch of Noramco Group, a North American pharmaceutical supply chain services provider.
Pharma Times
MARCH 15, 2024
Every year, missed hospital appointments are estimated to cost the NHS £1.
Pharmaceutical Technology
MARCH 15, 2024
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest trends and challenges in the digital therapeutics space.
pharmaphorum
MARCH 15, 2024
Consortium led by Birmingham University unveils a centre of excellence for medicines manufacturing training using VR, to answer a UK skills shortage.
XTalks
MARCH 15, 2024
LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab). Prescriptions sent to LillyDirect Pharmacy Solutions will be delivered through third-party dispensers that include online pharmacy Truepill and now Amazon Pharmacy,
pharmaphorum
MARCH 15, 2024
The ALS Association is partnering with myTomorrows to connect patients and physicians with clinical trials using a digital platform.
Pharmaceutical Commerce
MARCH 15, 2024
Reliance on foreign imports means that disruptions in the supply chain can profoundly impact the ability of individuals in the United States to get access to the medications they need.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
MARCH 15, 2024
Madrigal Pharma is first pharma company to get FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH)
Pharmaceutical Commerce
MARCH 15, 2024
The latest news for pharma industry insiders.
pharmaphorum
MARCH 15, 2024
Our latest round-up of funding rounds in the digital health category features updates from Healthee, Aktiia, Moxe Health, Eleanor Health, Tava Health, BrainCheck, and Redi Health.
Pharmaceutical Commerce
MARCH 15, 2024
Biosimilars market experiences massive growth, but regulatory and adoption challenges remain.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
MARCH 15, 2024
Over the last several decades, mounting interest has positioned bioconjugate therapeutics as one of the most promising biopharmaceutical modalities. | Antibody-drug conjugates are a promising biopharma modality but specialized expertise is instrumental for successfully bringing drugs to the clinic.
pharmaphorum
MARCH 15, 2024
Geron rockets after FDA advisory committee backs imetelstat as a treatment for transfusion-dependent myelodysplastic syndromes
Intouch Solutions
MARCH 15, 2024
In a recent article published by Med Ad News and PharmaLive.com , Hattie Stearns, Senior Director of Experience DesignOps, provides five key takeaways she observed as a brand and design lead at SXSW 2024. In the article, Hattie expands on each takeaway and highlights the responsibility we have as marketers to co-create and cultivate authentically. Art meets tech for healing and community Brands getting real Designing with heart and inclusivity Learning through stories AI with a human touch “Co-c
Fierce Pharma
MARCH 15, 2024
WuXi AppTec left the Biotechnology Industry Organization amid increasing pressure on the trade group stemming from a draft U.S. bill targeting certain Chinese biotechs. | WuXi AppTec left BIO amid alleged biosecurity concerns and as U.S. lawmakers target certain Chinese biotechs. Takeda will shut down a gene therapy manufacturing and R&D facility in Austria.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
317 
Let's personalize your content